• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recombinant DNA: an infectious disease perspective.

作者信息

Gorbach S L

出版信息

J Infect Dis. 1978 May;137(5):615-23. doi: 10.1093/infdis/137.5.615.

DOI:10.1093/infdis/137.5.615
PMID:351074
Abstract
摘要

相似文献

1
Recombinant DNA: an infectious disease perspective.重组DNA：从传染病角度看
J Infect Dis. 1978 May;137(5):615-23. doi: 10.1093/infdis/137.5.615.
2
Possible effects of foreign DNA on pathogenic potential and intestinal proliferation of Escherichia coli.外源DNA对大肠杆菌致病潜力和肠道增殖的潜在影响。
J Infect Dis. 1978 May;137(5):624-9. doi: 10.1093/infdis/137.5.624.
3
Pathogenesis of urinary tract infections: host susceptibility and bacterial virulence factors.尿路感染的发病机制：宿主易感性和细菌毒力因子
Urology. 1988 Sep;32(3 Suppl):9-11.
4
Bacterial adherence in urinary tract infections caused by Escherichia coli.大肠杆菌引起的尿路感染中的细菌黏附
Scand J Urol Nephrol. 1986;20(2):81-8. doi: 10.3109/00365598609040553.
5
[Uropathogenicity of E. coli].
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1989 Jan-Mar;34(1):43-8.
6
Intestine and environment of the chicken as reservoirs for extraintestinal pathogenic Escherichia coli strains with zoonotic potential.鸡的肠道和环境作为具有人畜共患病潜力的肠外致病性大肠杆菌菌株的储存库。
Appl Environ Microbiol. 2009 Jan;75(1):184-92. doi: 10.1128/AEM.01324-08. Epub 2008 Nov 7.
7
Urinary tract infection due to laboratory-acquired Escherichia coli: relation to virulence.实验室获得性大肠杆菌引起的尿路感染：与毒力的关系
Br Med J (Clin Res Ed). 1981 Mar 21;282(6268):949-50. doi: 10.1136/bmj.282.6268.949-a.
8
Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis.尿路致病性大肠杆菌在泌尿道发病机制中的细胞内细菌群落
Trends Microbiol. 2004 Sep;12(9):424-30. doi: 10.1016/j.tim.2004.07.005.
9
Transferable antibiotic resistance in Escherichia coli.大肠杆菌中的可转移抗生素耐药性。
Proc R Soc Med. 1971 May;64(5):533-4. doi: 10.1177/003591577106400530.
10
The spectrum of infections and pathogenic mechanisms of Escherichia coli.大肠杆菌的感染谱及致病机制
Adv Intern Med. 1988;33:231-52.

引用本文的文献

1
Safety of lacto-N-tetraose (LNT) produced by a derivative strain ( K-12 MG1655 INB_LNT_01) of K-12 MG1655 (ATCC 700926) as a novel food pursuant to Regulation (EU) 2015/2283.根据欧盟法规（EU）2015/2283，由K-12 MG1655（ATCC 700926）的衍生菌株（K-12 MG1655 INB_LNT_01）生产的乳糖-N-四糖（LNT）作为新型食品的安全性。
EFSA J. 2025 Aug 13;23(8):e9610. doi: 10.2903/j.efsa.2025.9610. eCollection 2025 Aug.
2
Safety of lacto-N-fucopentaose I/2'-fucosyllactose (LNFP-I/2'-FL) mixture as a novel food pursuant to Regulation (EU) 2015/2283.根据欧盟法规（EU）2015/2283，乳糖-N-岩藻五糖I/2'-岩藻糖基乳糖（LNFP-I/2'-FL）混合物作为新型食品的安全性。
EFSA J. 2023 Dec 1;21(12):e8412. doi: 10.2903/j.efsa.2023.8412. eCollection 2023 Dec.
3
Safety of 3'-Sialyllactose (3'-SL) sodium salt as a novel food pursuant to Regulation (EU) 2015/2283.根据欧盟法规（EU）2015/2283，3'-唾液酸乳糖（3'-SL）钠盐作为新型食品的安全性。
EFSA J. 2020 May 14;18(5):e06098. doi: 10.2903/j.efsa.2020.6098. eCollection 2020 May.
4
Safety of 6'-Sialyllactose (6'-SL) sodium salt as a novel food pursuant to Regulation (EU) 2015/2283.根据欧盟法规（EU）2015/2283，6'-唾液酸乳糖（6'-SL）钠盐作为新型食品的安全性。
EFSA J. 2020 May 14;18(5):e06097. doi: 10.2903/j.efsa.2020.6097. eCollection 2020 May.
5
Safety of 3-fucosyllactose (3-FL) produced by a derivative strain of K-12 DH1 as a novel food pursuant to Regulation (EU) 2015/2283.根据欧盟法规（EU）2015/2283，由K-12 DH1衍生菌株生产的3-岩藻糖基乳糖（3-FL）作为新型食品的安全性。
EFSA J. 2023 Jun 8;21(6):e08026. doi: 10.2903/j.efsa.2023.8026. eCollection 2023 Jun.
6
Safety and efficacy of a feed additive consisting of concentrated liquid l-lysine, l-lysine monohydrochloride and concentrated liquid l-lysine monohydrochloride produced by NITE BP-02917 for all animal species (Metex NoovistaGo).由日本技术评价研究所BP-02917生产的包含浓缩液L-赖氨酸、L-赖氨酸盐酸盐和浓缩液L-赖氨酸盐酸盐的饲料添加剂对所有动物物种（Metex NoovistaGo）的安全性和有效性。
EFSA J. 2022 Oct 25;20(10):e07612. doi: 10.2903/j.efsa.2022.7612. eCollection 2022 Oct.
7
Safety of 3-FL (3-Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283.根据欧盟法规（EU）2015/2283，3-岩藻糖基乳糖（3-FL）作为新型食品的安全性。
EFSA J. 2021 Jun 30;19(6):e06662. doi: 10.2903/j.efsa.2021.6662. eCollection 2021 Jun.
8
Safety of 2'-fucosyllactose/difucosyllactose mixture as a novel food pursuant to Regulation (EU) 2015/2283.根据欧盟法规（EU）2015/2283，2'-岩藻糖基乳糖/二岩藻糖基乳糖混合物作为新型食品的安全性。
EFSA J. 2019 Jun 11;17(6):e05717. doi: 10.2903/j.efsa.2019.5717. eCollection 2019 Jun.
9
Safety of lacto--tetraose (LNT) as a novel food pursuant to Regulation (EU) 2015/2283.根据欧盟法规（EU）2015/2283，乳糖四糖（LNT）作为新型食品的安全性。
EFSA J. 2019 Dec 3;17(12):e05907. doi: 10.2903/j.efsa.2019.5907. eCollection 2019 Dec.
10
Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.循证生物安全：微生物控制措施的原则与有效性综述
Clin Microbiol Rev. 2008 Jul;21(3):403-25. doi: 10.1128/CMR.00014-08.